229 related articles for article (PubMed ID: 20425631)
21. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.
Ferakis N; Bouropoulos C; Granitsas T; Mylona S; Poulias I
J Endourol; 2010 Dec; 24(12):1909-13. PubMed ID: 20946062
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Marshall FF
J Urol; 2005 Nov; 174(5):1782. PubMed ID: 16217284
[No Abstract] [Full Text] [Related]
23. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique?
Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J
Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
[TBL] [Abstract][Full Text] [Related]
25. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
26. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
27. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
29. Minimally invasive ablative technique for the treatment of small renal masses.
Gulur D; Crow P; Keeley FX
Arch Ital Urol Androl; 2009 Jun; 81(2):100-6. PubMed ID: 19760865
[TBL] [Abstract][Full Text] [Related]
30. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
31. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
32. Contemporary Status of Percutaneous Ablation for the Small Renal Mass.
Shin BJ; Chick JF; Stavropoulos SW
Curr Urol Rep; 2016 Mar; 17(3):23. PubMed ID: 26874535
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous image-guided radiofrequency ablation of renal malignancies.
Zagoria RJ
Radiol Clin North Am; 2003 Sep; 41(5):1067-75. PubMed ID: 14521210
[TBL] [Abstract][Full Text] [Related]
35. [Percutaneous thermal ablation of renal neoplasms].
Tacke J; Mahnken AH; Günther RW
Rofo; 2005 Dec; 177(12):1631-40. PubMed ID: 16333785
[TBL] [Abstract][Full Text] [Related]
36. Kidney cancer ablative therapy: indications and patient selection.
Lehman DS; Landman J
Curr Urol Rep; 2008 Jan; 9(1):34-43. PubMed ID: 18366972
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation.
McEachen JC; Leng S; Atwell TD; Tollefson MK; Friese JL; Wang Z; Murad MH; Schmit GD
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):233-8. PubMed ID: 26159355
[TBL] [Abstract][Full Text] [Related]
38. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous ablation in the kidney.
Venkatesan AM; Wood BJ; Gervais DA
Radiology; 2011 Nov; 261(2):375-91. PubMed ID: 22012904
[TBL] [Abstract][Full Text] [Related]
40. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.
Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM
J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
